Jackson JM - Search Results

1

Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study.

Gottlieb AB, Kircik L, Eisen D, Jackson JM, Boh EE, Strober BE, Frankel E, Xia HA, Stevens SR. Gottlieb AB, et al. Among authors: jackson jm. J Dermatolog Treat. 2006;17(6):343-52. doi: 10.1080/09546630600967166. J Dermatolog Treat. 2006. PMID: 17853307 Clinical Trial.

2

Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial.

Kimball AB, Jackson JM, Sobell JM, Boh EE, Grekin S, Pharmd EB, Woolley JM, Xia HA, Chiou CF, Stevens SR. Kimball AB, et al. Among authors: jackson jm. J Drugs Dermatol. 2007 Mar;6(3):299-306. J Drugs Dermatol. 2007. PMID: 17373192 Clinical Trial.

3

Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea.

Jackson JM, Kircik LH, Lorenz DJ. Jackson JM, et al. J Drugs Dermatol. 2013 Mar;12(3):292-8. J Drugs Dermatol. 2013. PMID: 23545911 Clinical Trial.

4

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study.

Strober B, Bagel J, Lebwohl M, Stein Gold L, Jackson JM, Chen R, Goncalves J, Levi E, Callis Duffin K. Strober B, et al. Among authors: jackson jm. J Drugs Dermatol. 2017 Aug 1;16(8):801-808. J Drugs Dermatol. 2017. PMID: 28809995 Clinical Trial.

5

Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis.

Webster G, Schaller M, Tan J, Jackson JM, Kerrouche N, Schäfer G. Webster G, et al. Among authors: jackson jm. J Dermatolog Treat. 2017 Aug;28(5):469-474. doi: 10.1080/09546634.2017.1343435. Epub 2017 Jul 4. J Dermatolog Treat. 2017. PMID: 28617145

6

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

Stein Gold L, Kircik L, Fowler J, Jackson JM, Tan J, Draelos Z, Fleischer A, Appell M, Steinhoff M, Lynde C, Sugarman J, Liu H, Jacovella J; Ivermectin Phase 3 Study Group. Stein Gold L, et al. Among authors: jackson jm. J Drugs Dermatol. 2014 Nov;13(11):1380-6. J Drugs Dermatol. 2014. PMID: 25607706 Clinical Trial.

7

Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients.

Jackson JM, Fowler JF Jr, Callen JP, Lorenz DJ. Jackson JM, et al. J Drugs Dermatol. 2010 Apr;9(4):356-62. J Drugs Dermatol. 2010. PMID: 20514793

8

A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.

Jackson JM, Fu JJ, Almekinder JL. Jackson JM, et al. J Drugs Dermatol. 2010 Feb;9(2):131-6. J Drugs Dermatol. 2010. PMID: 20214175 Clinical Trial.

9

The spectrum of nephrocutaneous diseases and associations: Inflammatory and medication-related nephrocutaneous associations.

Pascoe VL, Fenves AZ, Wofford J, Jackson JM, Menter A, Kimball AB. Pascoe VL, et al. Among authors: jackson jm. J Am Acad Dermatol. 2016 Feb;74(2):247-70; quiz 271-2. doi: 10.1016/j.jaad.2015.05.042. J Am Acad Dermatol. 2016. PMID: 26775774 Review.

10

Pyoderma gangrenosum: an update.

Callen JP, Jackson JM. Callen JP, et al. Among authors: jackson jm. Rheum Dis Clin North Am. 2007 Nov;33(4):787-802, vi. doi: 10.1016/j.rdc.2007.07.016. Rheum Dis Clin North Am. 2007. PMID: 18037117 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page